Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis

References

• Agarwal A, Agrawal H, Tiwari S, Jain S, Agrawal GP. 2011. Cationic ligand appended nanoconstructs: A prospective strategy for brain targeting. Int JPharm. 421:189–201.
   PubMed Web of Science ®Google Scholar
• Allen T, Hansen C, Guo L. 1993. Subcutaneous administration of liposomes: A comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta Biomemb. 1150:9–16.
   PubMed Web of Science ®Google Scholar
• Arseneault M, Wafer C, MORIN J-F. 2015. Recent advances in click chemistry applied to dendrimer synthesis. Molecules. 20:9263–9294.
   PubMed Web of Science ®Google Scholar
• Bahbouhi B, Pettré S, Berthelot L, Garcia A, Ngono AE, Degauque N, Michel L, Wiertlewski S, Lefrère F, Meyniel C. 2010. T-cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T-cells in multiple sclerosis. Brain. 133:1622–1636.
   PubMed Web of Science ®Google Scholar
• Bahrami B, Mohammadnia-Afrouzi M, Bakhshaei P, Yazdani Y, Ghalamfarsa G, Yousefi M, Sadreddini S, Jadidi-Niaragh F, Hojjat-Farsangi M. 2015. Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy. Tumor Biol. 36:5727–5742.
   PubMed Web of Science ®Google Scholar
• Bangham A, Standish MM, Watkins J. 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 13:238–252.
   PubMed Web of Science ®Google Scholar
• Barenholz YC. 2012. Doxil®—the first FDA-approved nano-drug: Lessons learned. J Control Release. 160:117–134.
   PubMed Web of Science ®Google Scholar
• Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, et al. 2008. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest. 118:1532.
   PubMed Web of Science ®Google Scholar
• Bataveljić D, Stamenković S, Bačić G, Andjus PR. 2011. Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis. Acta Physiol Hungarica. 98:27–31.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Han H-Y, Miller DW, Kabanov AV. 1998. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res. 15:1525–1532.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. 2008. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 130:98–106.
   PubMed Web of Science ®Google Scholar
• Battigelli A, Ménard-Moyon C, Da Ros T, Prato M, Bianco A. 2013. Endowing carbon nanotubes with biological and biomedical properties by chemical modifications. Adv Drug Deliv Rev 65:1899–1920.
   PubMed Web of Science ®Google Scholar
• Béduneau A, Hindré F, Clavreul A, Leroux J-C, Saulnier P, Benoit J-P. 2008. Brain targeting using novel lipid nanovectors. J Control Release. 126:44–49.
   PubMed Web of Science ®Google Scholar
• Béduneau A, Saulnier P, Hindré F, Clavreul A, Leroux J-C, Benoit J-P. 2007. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab’fragments. Biomaterials. 28:4978–4990.
   PubMed Web of Science ®Google Scholar
• Beg S, Samad AI, Alam M, Nazish I. 2011. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS Neurol Disord Drug Targets. 10:576–588.
   PubMed Web of Science ®Google Scholar
• Bencherif SA, Siegwart DJ, Srinivasan A, Horkay F, Hollinger JO, Washburn NR, Matyjaszewski K. 2009. Nanostructured hybrid hydrogels prepared by a combination of atom transfer radical polymerization and free radical polymerization. Biomaterials. 30:5270–5278.
   PubMed Web of Science ®Google Scholar
• Bertero A, Boni A, Gemmi M, Gagliardi M, Bifone A, Bardi G. 2014. Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood–brain barrier cells and the modulation of key inflammatory receptors on microglia. Nanotoxicology. 8:158–168.
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. 2015. Liposomes as nanomedical devices. Int J Nanomed 10:975–981.
   PubMed Web of Science ®Google Scholar
• Caporro M, Disanto G, Gobbi C, Zecca C. 2014. Two decades of subcutaneous glatiramer acetate injection: Current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment. Patient Prefer Adherence. 8:1123–1134.
   PubMed Web of Science ®Google Scholar
• Cappellano G, Woldetsadik AD, Orilieri E, Shivakumar Y, Rizzi M, Carniato F, Gigliotti CL, Boggio E, Clemente N, Comi C. 2014. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis. Vaccine. 32:5681–5689.
   PubMed Web of Science ®Google Scholar
• Cavaletti G, Cassetti A, Canta A, Galbiati S, Gilardini A, Oggioni N, Rodriguez-Menendez V, Fasano A, Liuzzi GM, Fattler U, et al. 2009. Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis. Mol Pharmaceut. 6:1363–1370.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Zastre J, Wong H-L, Wu XY, Bendayan R. 2008. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res. 25:2262–2271.
   PubMed Web of Science ®Google Scholar
• Chau NDQ, Ménard-Moyon C, Kostarelos K, Bianco A. 2015. Multifunctional carbon nanomaterial hybrids for magnetic manipulation and targeting. Biochem Biophys Res Commun. 468:454–462.
   PubMed Web of Science ®Google Scholar
• Chen D-B, Yang T-Z, Lu W-L, Zhang Q. 2001. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull. 49:1444–1447.
   PubMed Web of Science ®Google Scholar
• Cheng M-R, Li Q, Wan T, He B, Han J, Chen H-X, Yang F-X, Wang W, Xu H-Z, Ye T. 2012. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects. World J Gastroenterol. 18:6076.
   PubMed Web of Science ®Google Scholar
• Chowdhary RK, Chansarkar N, Sharif I, Hioka N, Dolphin D. 2003. Formulation of benzoporphyrin derivatives in pluronics. Photochem Photobiol. 77:299–303.
   PubMed Web of Science ®Google Scholar
• Christenson RH, Cervelli DR, Bauer RS, Gordon M. 2004. Stratus® CS cardiac troponin I method: Performance characteristics including imprecision at low concentrations. Clin Biochem. 37:679–683.
   PubMed Web of Science ®Google Scholar
• Claire du Toit L, Pillay V, Choonara YE, Pillay S, Harilall S-L. 2007. Patenting of nanopharmaceuticals in drug delivery: No small issue. Recent Patents Drug Deliv Formulation. 1:131–142.
   PubMedGoogle Scholar
• Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G, Newcombe J. 1996. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution. J Neuropathol Exp Neurol. 55:1194–1204.
   PubMed Web of Science ®Google Scholar
• Dai H, Navath RS, Balakrishnan B, Guru BR, Mishra MK, Romero R, Kannan RM, Kannan S. 2010. Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine. 5:1317–1329.
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. 2009. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Control Release. 133:11–17.
   PubMed Web of Science ®Google Scholar
• Dash PR, Read ML, Fisher KD, Howard KA, Wolfert M, Oupicky D, Subr V, Strohalm J, Ulbrich K, Seymour LW. 2000. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J Biol Chem. 275:3793–3802.
   PubMed Web of Science ®Google Scholar
• De Jesus MB, Zuhorn IS. 2015. Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms. J Control Release. 201:1–13.
   PubMed Web of Science ®Google Scholar
• Dellinger A, Zhou Z, Connor J, Madhankumar A, Pamujula S, Sayes CM, Kepley CL. 2013. Application of fullerenes in nanomedicine: An update. Nanomedicine. 8:1191–1208.
   PubMed Web of Science ®Google Scholar
• Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R. 2008. Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2. J Neurochem. 106:1534–1544.
   PubMed Web of Science ®Google Scholar
• Dhanikula RS, Argaw A, Bouchard J-F, Hildgen P. 2008. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: Enhanced efficacy and intratumoral transport capability. Mol Pharm. 5:105–116.
   PubMed Web of Science ®Google Scholar
• Dhawan S, Kapil R, Singh B. 2011. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J Pharm Pharmacol. 63:342–351.
   PubMed Web of Science ®Google Scholar
• Donaghue IE, Tam R, Sefton MV, Shoichet MS. 2014. Cell and biomolecule delivery for tissue repair and regeneration in the central nervous system. J Control Release. 190:219–227.
   PubMed Web of Science ®Google Scholar
• Dunne M, Corrigan O, Ramtoola Z. 2000. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials. 21:1659–1668.
   PubMed Web of Science ®Google Scholar
• Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD. 2013. Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo. J Neuroinflammation. 10:138.
   PubMed Web of Science ®Google Scholar
• Eitan E, Hutchison ER, Greig NH, Tweedie D, Celik H, Ghosh S, Fishbein KW, Spencer RG, Sasaki CY, Ghosh P. 2015. Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity. Exp Neurol. 273:151–160.
   PubMed Web of Science ®Google Scholar
• Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J. 2007. “Pathogen-mimicking” nanoparticles for vaccine delivery to dendritic cells. J Immunother. 30:378–395.
   PubMed Web of Science ®Google Scholar
• Esfand R, Tomalia DA. 2001. Poly (amidoamine)(PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today. 6:427–436.
   PubMed Web of Science ®Google Scholar
• Foley CP, Nishimura N, Neeves KB, Schaffer CB, Olbricht WL. 2012. Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex. Ann Biomed Eng. 40:292–303.
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm. 168:221–229.
   Web of Science ®Google Scholar
• Freitas RA. 2005. Nanotechnology, nanomedicine and nanosurgery. Int J Surg. 3:243–246.
   PubMedGoogle Scholar
• Führmann T, Ghosh M, Otero A, Goss B, Pearse DD, Dalton PD. 2015. Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis. Neurosci Lett. 602:126–132.
   PubMed Web of Science ®Google Scholar
• Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. 2000. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after iv administration to rats. Pharmacol Res. 42:337–343.
   PubMed Web of Science ®Google Scholar
• Gammon JM, Tostanoski LH, Adapa AR, Chiu Y-C, Jewell CM. 2015. Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity. J Control Release. 210:169–178.
   PubMed Web of Science ®Google Scholar
• Ganta S, Deshpande D, Korde A, Amiji M. 2010. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers. Mol Membr Biol. 27:260–273.
   PubMed Web of Science ®Google Scholar
• Ganta S, Paxton JW, Baguley BC, Garg S. 2008. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int J Pharm. 360:115–121.
   PubMed Web of Science ®Google Scholar
• Ganta S, Singh A, Kulkarni P, Keeler AW, Piroyan A, Sawant RR, Patel NR, Davis B, Ferris C, O’Neal S. 2015. EGFR targeted theranostic nanoemulsion for image-guided ovarian cancer therapy. Pharm Res 32:2753–2763.
   PubMed Web of Science ®Google Scholar
• Gao H, Pang Z, Jiang X. 2013. Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm Res 30:2485–2498.
   PubMed Web of Science ®Google Scholar
• Gao X, Wu B, Zhang Q, Chen J, Zhu J, Zhang W, Rong Z, Chen H, Jiang X. 2007. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J Control Release. 121:156–167.
   PubMed Web of Science ®Google Scholar
• Georganopoulou DG, Chang L, Nam J-M, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA. 2005. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci USA. 102:2273–2276.
   PubMed Web of Science ®Google Scholar
• Ghabaee M, Jabedari B, Al-E-Eshagh N, Ghaffarpour M, Asadi F. 2010. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients. Int J Neurosci. 120:301–304.
   PubMed Web of Science ®Google Scholar
• Ghalamfarsa G, Mahmoudi M, Mohammadnia-Afrouzi M, Yazdani Y, Anvari E, Hadinia A, Ghanbari A, Setayesh M, Yousefi M, Jadidi-Niaragh F. 2015. IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. J Immunotoxicol. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M. 2015. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Cell Immunol. 293:113–121.
   PubMed Web of Science ®Google Scholar
• Ginocchio CC. 2011. Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens. Clin Infect Dis. 52:S312–S325.
   PubMedGoogle Scholar
• Gonzalo H, Brieva L, Tatzber F, Jové M, Cacabelos D, Cassanyé A, Lanau‐Angulo L, Boada J, Serrano JC, González C. 2012. Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. J Neurochem. 123:622–634.
   PubMed Web of Science ®Google Scholar
• Gosselin MA, Lee RJ. 2002. Folate receptor-targeted liposomes as vectors for therapeutic agents. Biotechnol Annu Rev. 8:103–131.
   PubMedGoogle Scholar
• Graf A, Rades T, Hook SM. 2009. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: Optimization and in vivo evaluation. Eur J Pharm Sci. 37:53–61.
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain SK. 2007. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol. 59:935–940.
   PubMed Web of Science ®Google Scholar
• Haes AJ, Chang L, Klein WL, van Duyne RP. 2005. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor. J Am Chem Soc. 127:2264–2271.
   PubMed Web of Science ®Google Scholar
• Hawker CJ, Frechet JM. 1990. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J Am Chem Soc. 112:7638–7647.
   Web of Science ®Google Scholar
• Heckman KL, Decoteau W, Estevez A, Reed KJ, Costanzo W, Sanford D, Leiter JC, Clauss J, Knapp K, Gomez C. 2013. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano. 7:10582–10596.
   PubMed Web of Science ®Google Scholar
• Hemmer R, Hall A, Spaulding R, Rossow B, Hester M, Caroway M, Haskamp A, Wall S, Bullen HA, Morris C. 2013. Analysis of biotinylated generation 4 poly (amidoamine)(PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier. Molecules. 18:11537–11552.
   PubMed Web of Science ®Google Scholar
• Hoepner R, Faissner S, Salmen A, Gold R, Chan A. 2014. Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis. J Central Nerv Syst Dis. 6:41–49.
   PubMedGoogle Scholar
• Høglund RA, Maghazachi AA. 2014. Multiple sclerosis and the role of immune cells. World J Exp Med. 4:27–37.
   PubMedGoogle Scholar
• Hosseini A, Sharifi AM, Abdollahi M, Najafi R, Baeeri M, Rayegan S, Cheshmehnour J, Hassani S, Bayrami Z, Safa M. 2014. Cerium and yttrium oxide nanoparticles against lead-induced oxidative stress and apoptosis in rat hippocampus. Biol Trace Element Res. 164:80–89.
   PubMed Web of Science ®Google Scholar
• Hosseini M, Haji-Fatahaliha M, Jadidi-Niaragh F, Majidi J, Yousefi M. 2015. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy. Artif Cells Nanomed Biotechnol. [Epub ahead of print].
   Google Scholar
• Hsiao JK, Chu HH, Wang YH, Lai CW, Chou PT, Hsieh ST, Wang JL, Liu HM. 2008. Macrophage physiological function after superparamagnetic iron oxide labeling. NMR Biomed. 21:820–829.
   PubMed Web of Science ®Google Scholar
• Hu W, Metselaar J, Ben L-H, Cravens PD, Singh MP, Frohman EM, Eagar TN, Racke MK, Kieseier BC, Stüve O. 2009. PEG minocycline-liposomes ameliorate CNS autoimmune disease. PLoS One. 4:e4151.
   PubMed Web of Science ®Google Scholar
• Huang R, Ke W, Liu Y, Jiang C, Pei Y. 2008. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials. 29:238–246.
   PubMed Web of Science ®Google Scholar
• Hunger M, Budinger E, Zhong K, Angenstein F. 2014. Visualization of acute focal lesions in rats with experimental autoimmune encephalomyelitis by magnetic nanoparticles, comparing different MRI sequences including phase imaging. J Magn Resonance Imaging. 39:1126–1135.
   PubMed Web of Science ®Google Scholar
• Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD. 2014. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano. 8:2148–2160.
   PubMed Web of Science ®Google Scholar
• Hwang SR, Kim K. 2014. Nano-enabled delivery systems across the blood–brain barrier. Arch Pharm Res. 37:24–30.
   PubMed Web of Science ®Google Scholar
• Illum L. 2004. Is nose‐to‐brain transport of drugs in man a reality? J Pharm Pharmacol. 56:3–17.
   PubMed Web of Science ®Google Scholar
• Jackson AL, Linsley PS. 2010. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov. 9:57–67.
   PubMed Web of Science ®Google Scholar
• Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH. 1996. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol. 39:285–294.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Atyabi F, Rastegari A, Mollarazi E, Kiani M, Razavi A, Yousefi M, Kheshtchin N, Hassannia H, Hadjati J. 2016. Down-regulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles. Tumor Biol. [Epub ahead of print].
   Web of Science ®Google Scholar
• Jadidi-Niaragh F, Mirshafiey A. 2010. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology. 59:180–189.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Mirshafiey A. 2011a. Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis. Immunopharmacol Immunotoxicol. 33:545–567.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Mirshafiey A. 2011b. TH17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol. 74:1–13.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Mirshafiey A. 2011c. Therapeutic approach to multiple sclerosis by novel oral drugs. Recent Patents Inflamm Allergy Drug Discov. 5:66–80.
   PubMedGoogle Scholar
• Jadidi-Niaragh F, Mirshafiey A. 2012. The deviated balance between regulatory T-cell and TH17 in autoimmunity. Immunopharmacol Immunotoxicol. 34:727–739.
   PubMed Web of Science ®Google Scholar
• Jang JS, Kim SY, Lee SB, Kim KO, Han JS, Lee YM. 2006. Poly (ethylene glycol)/poly (ɛ-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: The role of charge group and molecular weight in particle formation, cytotoxicity and transfection. J Control Release. 113:173–182.
   PubMed Web of Science ®Google Scholar
• Javaheri-Kermani M, Farazmandfar T, Ajami A, Yazdani Y. 2014. Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients. Scand J Infect Dis. 46:693–696.
   PubMed Web of Science ®Google Scholar
• Jeffries GD, Edgar JS, Zhao Y, Shelby JP, Fong C, Chiu DT. 2007. Using polarization-shaped optical vortex traps for single-cell nanosurgery. Nano Lett. 7:415–420.
   PubMed Web of Science ®Google Scholar
• Jenkins SI, Pickard MR, Granger N, Chari DM. 2011. Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies. ACS Nano. 5:6527–6538.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Miller DW. 2003. Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv Drug Deliv Rev. 55:151–164.
   PubMed Web of Science ®Google Scholar
• Kanazawa T. 2015. Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles. Med Devices (Auckland, NZ). 8:57–64.
   PubMedGoogle Scholar
• Kanazawa T, Taki H, Tanaka K, Takashima Y, Okada, H. 2011. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration. Pharm Res. 28:2130–2139.
   PubMed Web of Science ®Google Scholar
• Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, Romero R, Kannan RM. 2012. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med. 4:130ra46.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou S-F, Chauhan A, Kanwar RK. 2012. Nanoparticles in the treatment and diagnosis of neurological disorders: Untamed dragon with fire power to heal. Nanomed Nanotechnol Biol Med. 8:399–414.
   PubMed Web of Science ®Google Scholar
• Karmakar A, Xu Y, Mahmood MW, Zhang Y, Saeed LM, Mustafa T, Ali S, Biris AR, Biris AS. 2011. Radio-frequency induced in vitro thermal ablation of cancer cells by EGF functionalized carbon-coated magnetic nanoparticles. J Mater Chem. 21:12761–12769.
   Web of Science ®Google Scholar
• Kasper LH, Reder AT. 2014. Immunomodulatory activity of interferon‐beta. Ann Clin Transl Neurol. 1:622–631.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandari R, Bhandari S, Kakkar V. 2008. Potential of solid lipid nanoparticles in brain targeting. J Control Release. 127:97–109.
   PubMed Web of Science ®Google Scholar
• Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C. 2009a. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials. 30:6976–6985.
   PubMed Web of Science ®Google Scholar
• Ke Y-Q, Hu C-C, Jiang X-D, Yang Z-J, Zhang H-W, Ji H-M, Zhou L-Y, Cai Y-Q, Qin L-S, Xu R-X. 2009b. In vivo magnetic resonance tracking of Feridex-labeled bone marrow-derived neural stem cells after autologous transplantation in rhesus monkey. J Neurosci Methods. 179:45–50.
   PubMed Web of Science ®Google Scholar
• Keliher EJ, Yoo J, Nahrendorf M, Lewis JS, Marinelli B, Newton A, Pittet MJ, Weissleder R. 2011. 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjug Chem. 22:2383–2389.
   PubMed Web of Science ®Google Scholar
• Kempiński W, Łoś S, Kempiński M, Markowski D. 2014. Experimental techniques for the characterization of carbon nanoparticles–a brief overview. Beilstein J Nanotechnol. 5:1760–1766.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Tekade RK, Jain NK. 2014a. Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector. Nanomedicine. 9:2291–2308.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Tekade RK, Jain NK. 2014b. Generation dependent cancer targeting potential of poly (propyleneimine) dendrimer. Biomaterials. 35:5539–5548.
   PubMed Web of Science ®Google Scholar
• Khawaja AM. 2011. The legacy of nanotechnology: Revolution and prospects in neurosurgery. Int J Surg. 9:608–614.
   PubMed Web of Science ®Google Scholar
• Kim D-H, Martin DC. 2006. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials. 27:3031–3037.
   PubMed Web of Science ®Google Scholar
• Kim W, Zandoná ME, Kim S-H, Kim HJ. 2015. Oral disease-modifying therapies for multiple sclerosis. J Clin Neurol. 11:9–19.
   PubMed Web of Science ®Google Scholar
• Kircheis R, Blessing T, Brunner S, Wightman L, Wagner E. 2001. Tumor targeting with surface-shielded ligand–polycation DNA complexes. J Control Release. 72:165–170.
   PubMed Web of Science ®Google Scholar
• Kizelsztein P, Ovadia H, Garbuzenko O, Sigal A, Barenholz Y. 2009. Pegylated nanoliposomes remote-loaded with the anti-oxidant tempamine ameliorate experimental autoimmune encephalomyelitis. J Neuroimmunol. 213:20–25.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Jo S-K, Kawamoto S, Yasuda H, Hu X, Knopp MV, Brechbiel MW, Choyke PL, Star RA. 2004. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magn Resonan Imaging. 20:512–518.
   PubMed Web of Science ®Google Scholar
• Kokhaei P, Jadidi-Niaragh F, Sotoodeh Jahromi A, Osterborg A, Mellstedt H, Hojjat-Farsangi M. 2015. Ibrutinib-A double-edge sword in cancer and autoimmune disorders. J Drug Target. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Koshkaryev A, Piroyan A, Torchilin VP. 2012. Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes. Cancer Biol Ther. 13:50–60.
   PubMed Web of Science ®Google Scholar
• Kothamasu P, Kanumur H, Ravur N, Maddu C, Parasuramrajam R, Thangavel S. 2012. Nanocapsules: The weapons for novel drug delivery systems. BioImpacts. 2:71–81.
   PubMedGoogle Scholar
• Krishnamachari Y, Geary SM, Lemke CD, Salem AK. 2011. Nanoparticle delivery systems in cancer vaccines. Pharm Res. 28:215–236.
   PubMed Web of Science ®Google Scholar
• Kumar M, Misra A, Mishra A, Mishra P, Pathak K. 2008. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J Drug Target 16:806–814.
   PubMed Web of Science ®Google Scholar
• Kuo Y-C, Chen H-H. 2006. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate–sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood–brain barrier. Int J Pharm. 327:160–169.
   PubMed Web of Science ®Google Scholar
• Lamprecht C, Hinterdorfer P, Ebner A. 2014. Applications of biosensing atomic force microscopy in monitoring drug and nanoparticle delivery. Expert Opin Drug Deliv. 11:1237–1253.
   PubMed Web of Science ®Google Scholar
• Landau AJ, Eberhardt RT, Frishman WH. 1994. Intranasal delivery of cardiovascular agents: An innovative approach to cardiovascular pharmacotherapy. Am Heart J. 127:1594–1599.
   PubMed Web of Science ®Google Scholar
• Leamon CP, Low PS. 2001. Folate-mediated targeting: From diagnostics to drug and gene delivery. Drug Discov Today. 6:44–51.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Seo HS, Song JA, Kwon KC, Lee EJ, Kim HJ, Lee EB, Cha YJ, Lee J. 2013. Proteinticle engineering for accurate 3D diagnosis. ACS Nano. 7:10879–10886.
   PubMed Web of Science ®Google Scholar
• Lee J, Nikolov A, Wasan D. 2014. Surfactant micelles containing solubilized oil decrease foam film thickness stability. J Colloid Interface Sci. 415:18–25.
   PubMed Web of Science ®Google Scholar
• Letchford K, Burt H. 2007. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: Micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 65:259–269.
   PubMed Web of Science ®Google Scholar
• Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, Kira J-I. 2007. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol. 184:227–231.
   PubMed Web of Science ®Google Scholar
• Libbey JE, Cusick MF, Fujinami RS. 2014. Role of pathogens in multiple sclerosis. Int Rev Immunol. 33:266–283.
   PubMed Web of Science ®Google Scholar
• Linker RA, Weller C, Lühder F, Mohr A, Schmidt J, Knauth M, Metselaar JM, Gold R. 2008. Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: Long-term protective effects and enhanced efficacy of methylprednisolone formulations. Exp Neurol. 211:397–406.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang H, Yang W, Cheng Y. 2012. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. J Am Chem Soc. 134:17680–17687.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li J, Shao K, Huang R, Ye L, Lou J, Jiang C. 2010. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. Biomaterials. 31:5246–5257.
   PubMed Web of Science ®Google Scholar
• Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD. 2003. Brain uptake of thiamine-coated nanoparticles. J Control Release. 93:271–282.
   PubMed Web of Science ®Google Scholar
• Lu C-T, Zhao Y-Z, Wong HL, Cai J, Peng L, Tian X-Q. 2014. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine. 9:2241–2257.
   PubMed Web of Science ®Google Scholar
• Lutsenko S, Feldman N, Severin S. 2002. Cytotoxic and anti-tumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragment. J Drug Target. 10:567–571.
   PubMed Web of Science ®Google Scholar
• Machtoub L, Pfeiffer R, Backovic A, Frischauf S, Wick MC. 2010. Molecular imaging cellular SPIO uptake with nonlinear optical microscopy. J Med Imaging Radiat Sci. 41:159–164.
   Google Scholar
• Madaan K, Kumar S, Poonia N, Lather V, Pandita D. 2014. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharmacy Bioallied Sci. 6:139–150.
   PubMedGoogle Scholar
• Mahmoudi M, Sahraian MA, Shokrgozar MA, Laurent S. 2011. Superparamagnetic iron oxide nanoparticles: Promises for diagnosis and treatment of multiple sclerosis. ACS Chem Neurosci. 2:118–140.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3:1377–1397.
   PubMed Web of Science ®Google Scholar
• Marcato PD, Durán N. 2008. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol. 8:2216–2229.
   PubMed Web of Science ®Google Scholar
• Maruyama K, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M. 1997. Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett. 413:177–180.
   PubMed Web of Science ®Google Scholar
• Menjoge AR, Kannan RM, Tomalia DA. 2010. Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications. Drug Discov Today. 15:171–185.
   PubMed Web of Science ®Google Scholar
• Merodio M, Irache JM, Eclancher F, Mirshahi M, Villarroya H. 2000. Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis. J Drug Target. 8:289–303.
   PubMed Web of Science ®Google Scholar
• Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K. 2006. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther. 317:1246–1253.
   PubMed Web of Science ®Google Scholar
• Miljković D, Spasojević I. 2013. Multiple sclerosis: Molecular mechanisms and therapeutic opportunities. Antioxidants Redox Signal. 19:2286–2334.
   PubMed Web of Science ®Google Scholar
• Mirshafiey A, Asghari B, Ghalamfarsa G, Jadidi-Niaragh F, Azizi G. 2014. The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis. Sultan Qaboos Univ Med J. 14:e13.
   Google Scholar
• Mirshafiey A, Jadidi-Niaragh F. 2010a. Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis. Immunopharmacol Immunotoxicol. 32:219–227.
   PubMed Web of Science ®Google Scholar
• Mirshafiey A, Jadidi-Niaragh F. 2010b. Prostaglandins in pathogenesis and treatment of multiple sclerosis. Immunopharmacol Immunotoxicol. 32:543–554.
   PubMed Web of Science ®Google Scholar
• Monaco AM, Giugliano M. 2014. Carbon-based smart nanomaterials in biomedicine and neuroengineering. Beilstein J Nanotechnol. 5:1849–1863.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery – A review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
   PubMed Web of Science ®Google Scholar
• Nance EA, Woodworth GF, Sailor KA, Shih T-Y, Xu Q, Swaminathan G, Xiang D, Eberhart C, Hanes J. 2012. A dense poly-(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med. 4:149ra119.
   PubMed Web of Science ®Google Scholar
• Nayak S, Lee H, Chmielewski J, Lyon LA. 2004. Folate-mediated cell targeting and cytotoxicity using thermoresponsive microgels. J Am Chem Soc. 126:10258–10259.
   PubMed Web of Science ®Google Scholar
• Neely A, Perry C, Varisli B, Singh AK, Arbneshi T, Senapati D, Kalluri JR, Ray PC. 2009. Ultrasensitive and highly selective detection of Alzheimer’s disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticle. ACS Nano. 3:2834–2840.
   PubMed Web of Science ®Google Scholar
• Neuwelt A, Sidhu N, Hu C-AA, Mlady G, Eberhardt SC, Sillerud LO. 2015. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. Am J Roentgenol. 204:W302.
   PubMed Web of Science ®Google Scholar
• Niu R, Zhao P, Wang H, Yu M, Cao S, Zhang F, Chang J. 2011. Preparation, characterization, and anti-tumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes. J Drug Target. 19:373–381.
   PubMed Web of Science ®Google Scholar
• Niven RW, Speer M, Schreier H. 1991. Nebulization of liposomes. II. The effects of size and modeling of solute release profiles. Pharm Res. 8:217–221.
   PubMed Web of Science ®Google Scholar
• Obataya I, Nakamura C, Han S, Nakamura N, Miyake J. 2005. Nanoscale operation of a living cell using an atomic force microscope with a nanoneedle. Nano Lett. 5:27–30.
   PubMed Web of Science ®Google Scholar
• Ogris M, Brunner S, Schüller S, Kircheis R, Wagner E. 1999. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:595–605.
   PubMed Web of Science ®Google Scholar
• Ortiz GG, Pacheco-Moisés FP, Bitzer-Quintero OK, Ramírez-Anguiano AC, Flores-Alvarado LJ, Ramírez-Ramírez V, Macias-Islas MA, Torres-Sánchez ED. 2013. Immunology and oxidative stress in multiple sclerosis: Clinical and basic approach. Clin Dev Immunol. 2013.
   PubMedGoogle Scholar
• Ortiz GG, Pacheco-Moisés FP, Macías-Islas MÁ, Flores-Alvarado LJ, Mireles-Ramírez MA, González-Renovato ED, Hernández-Navarro VE, Sánchez-López AL, Alatorre-Jiménez MA. 2014. Role of the blood-brain barrier in multiple sclerosis. Arch Med Res. 45:687–697.
   PubMed Web of Science ®Google Scholar
• Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW. 2002. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther. 5:463–472.
   PubMed Web of Science ®Google Scholar
• Oyewumi MO, Liu S, Moscow JA, Mumper RJ. 2003. Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters. Bioconj Chem. 14:404–411.
   PubMed Web of Science ®Google Scholar
• Paiphansiri U, Tangboriboonrat P, Landfester K. 2007. Antiseptic nanocapsule formation via controlling polymer deposition onto water‐in‐oil miniemulsion droplets. Macromol Biosci. 6:33–40.
   Web of Science ®Google Scholar
• Pardridge WM, Kang Y-S, Buciak JL, Yang, J. 1995. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood–brain barrier in vivo in the primate. Pharm Res. 12:807–816.
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Wu D, Sakane T. 1998. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharm Res. 15:576–582.
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. 2008. Polymeric nanoparticles for cancer therapy. J Drug Target. 16:108–123.
   PubMed Web of Science ®Google Scholar
• Patlolla RR, Vobalaboina V. 2008. Folate-targeted etoposide-encapsulated lipid nanospheres. J Drug Target. 16:269–275.
   PubMed Web of Science ®Google Scholar
• Patton D, Sweeney YC, Mccarthy T, Hillier S. 2006. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a non-human primate model. Antimicrob Agents Chemother. 50:1696–1700.
   PubMed Web of Science ®Google Scholar
• Pezeshki MZ, Zarrintan S, Zarrintan MH. 2008. Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. Med Hypotheses. 70:1223.
   PubMed Web of Science ®Google Scholar
• Ponomarev ED, Shriver LP, Maresz K, Dittel BN. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res. 81:374–389.
   PubMed Web of Science ®Google Scholar
• Popescu BFG, Lucchinetti CF. 2012. Pathology of demyelinating diseases. Annu Rev Pathol Mech Dis. 7:185–217.
   PubMed Web of Science ®Google Scholar
• Prabhu RH, Patravale VB, Joshi MD. 2015. Polymeric nanoparticles for targeted treatment in oncology: Current insights. Int J Nanomedicine. 10:1001.
   PubMed Web of Science ®Google Scholar
• Rajagopalan R, Xavier J, Rangaraj N, Rao NM, Gopal V. 2007a. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. J Gene Med. 9:275–286.
   PubMed Web of Science ®Google Scholar
• Rajagopalan R, Xavier J, Rangaraj N, Rao NM, Gopal V. 2007b. Recombinant fusion proteins TAT‐Mu, Mu and Mu‐Mu mediate efficient non‐viral gene delivery. J Gene Med. 9:275–286.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM, Engelhardt B. 2012. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 12:623–635.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM, Hafler DA, Lucchinetti CF. 2015. Multiple sclerosis — A quiet revolution. Nat Rev Neurol. 11:134–142.
   PubMed Web of Science ®Google Scholar
• Reddy LH, Sharma R, Chuttani K, Mishra A, Murthy R. 2005. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. J Control Release. 105:185–198.
   PubMed Web of Science ®Google Scholar
• Reddy MK, Labhasetwar V. 2009. Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23:1384–1395.
   PubMed Web of Science ®Google Scholar
• Rittchen S, Boyd A, Burns A, Park J, Fahmy TM, Metcalfe S, Williams A. 2015. Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF). Biomaterials. 56:78–85.
   PubMed Web of Science ®Google Scholar
• Rostami E, Kashanian S, Azandaryani AH, Faramarzi H, Dolatabadi JEN, Omidfar K. 2014. Drug targeting using solid lipid nanoparticles. Chem Phys Lipids. 181:56–61.
   PubMed Web of Science ®Google Scholar
• Rupp R, Rosenthal SL, Stanberry LR. 2007. VivaGel™(SPL7013 Gel): A candidate dendrimer–microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine. 2:561–566.
   PubMed Web of Science ®Google Scholar
• Rutishauser H, Gutknecht M. 1976. Parabolische und hyperbolische partielle Differentialgleichungen. Vorlesungen über Numerische Mathematik. Basel: Springer.
   Google Scholar
• Sarker DK. 2005. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv. 2:297–310.
   PubMedGoogle Scholar
• Schäfer R, Ayturan M, Bantleon R, Kehlbach R, Siegel G, Pintaske J, Conrad S, Wolburg H, Northoff H, Wiskirchen J. 2008. The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution. Cell Transpl. 17:923–941.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Metselaar JM, Wauben MH, Toyka KV, Storm G, Gold R. 2003. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain. 126:1895–1904.
   PubMed Web of Science ®Google Scholar
• Schubert D, Dargusch R, Raitano J, Chan S-W. 2006. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun. 342:86–91.
   PubMed Web of Science ®Google Scholar
• Sestak JO, Fakhari A, Badawi AH, Siahaan TJ, Berkland C. 2014. Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis. AAPS J. 16:1185–1193.
   PubMed Web of Science ®Google Scholar
• Shen Y, Jin E, Zhang B, Murphy CJ, Sui M, Zhao J, Wang J, Tang J, Fan M, Van Kirk E. 2010. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc. 132:4259–4265.
   PubMed Web of Science ®Google Scholar
• Siglienti I, Bendszus M, Kleinschnitz C, Stoll G. 2006. Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging. J Neuroimmunol. 173:166–173.
   PubMed Web of Science ®Google Scholar
• Silva A, González-Mira E, García M, Egea M, Fonseca J, Silva R, Santos D, Souto E, Ferreira D. 2011. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces. 86:158–165.
   PubMed Web of Science ®Google Scholar
• Soni S, Babbar AK, Sharma RK, Maitra A. 2006. Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels. J Drug Target. 14:87–95.
   PubMed Web of Science ®Google Scholar
• Stevens PJ, Sekido M, Lee RJ. 2004. A folate receptor–targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res. 21:2153–2157.
   PubMed Web of Science ®Google Scholar
• Stoll G, Bendszus M. 2010. New approaches to neuroimaging of central nervous system inflammation. Curr Opin Neurol. 23:282–286.
   PubMed Web of Science ®Google Scholar
• Surtees RA, Rodeck C, Clayton PT. 1992. Aromatic L-amino acid decarboxylase deficiency: Clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology. 42:1980–1988.
   PubMed Web of Science ®Google Scholar
• Svenson S, Chauhan AS, Reyna LA, Tomalia DA. 2006. Starburst® and Priostar™ dendrimers for controlled drug delivery applications. Polym Preprints. 47:150.
   Google Scholar
• Taogoshi T, Nomura A, Murakami T, Nagai J, Takano M. 2005. Transport of prostaglandin E1 across the blood‐brain barrier in rats. J Pharm Pharmacol. 57:61–66.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Müller RH, Junyaprasert VB. 2007. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) – Effects of formulation parameters on physicochemical stability. Int J Pharm. 340:198–206.
   PubMed Web of Science ®Google Scholar
• Tian X-H, Lin X-N, Wei F, Feng W, Huang Z-C, Wang P, Ren L, Diao Y. 2011. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine. 6:445–452.
   PubMed Web of Science ®Google Scholar
• Tila D, Ghasemi S, Yazdani-Arazi SN, Ghanbarzadeh S. 2015. Functional liposomes in the cancer-targeted drug delivery. J Biomater Appl. 30:3–16.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Tan Y-M, Amiji M. 2006. Preparation and in vitro characterization of multifunctional nanoemulsions for simultaneous MR imaging and targeted drug delivery. J Biomed Nanotechnol. 2:217–224.
   Web of Science ®Google Scholar
• Tomalia DA, Fréchet JM. 2002. Discovery of dendrimers and dendritic polymers: A brief historical perspective. J Polym Sci A Polym Chem 40:2719–2728.
   Web of Science ®Google Scholar
• Vanpouille-Box C, Lacoeuille F, Roux J, Aubé C, Garcion E, Lepareur N, Oberti F, Bouchet F, Noiret N, Garin E. 2011. Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. PLoS One. 6:e16926.
   Google Scholar
• Venishetty VK, Samala R, Komuravelli R, Kuncha M, Sistla R, Diwan PV. 2013. β-Hydroxybutyric acid grafted solid lipid nanoparticles: A novel strategy to improve drug delivery to brain. Nanomedicine Nanotechnol Biol Med. 9:388–397.
   PubMed Web of Science ®Google Scholar
• Vinogradov S, Batrakova E, Kabanov A. 1999. Poly-(ethylene glycol)–polyethyleneimine NanoGel™ particles: Novel drug delivery systems for antisense oligonucleotides. Colloids Surf B Biointerfaces. 16:291–304.
   Web of Science ®Google Scholar
• Vinogradov SV. 2007. Polymeric nanogel formulations of nucleoside analogs. Expert Opin Drug Deliv. 4:5–17.
   PubMed Web of Science ®Google Scholar
• Vinogradov SV, Batrakova EV, Kabanov AV. 2004. Nanogels for oligonucleotide delivery to the brain. Bioconj Chem. 15:50–60.
   PubMed Web of Science ®Google Scholar
• Vinogradov SV, Kabanov AV. 2004. Synthesis of Nanogel carriers for delivery of active phosphorylated nucleoside analogues. In: Papers presented at the meeting of American Chemical Society. Division of Polymer Chemistry. NIH Public Access. Polymer Prepr. 228(Pt 2):296.
   Google Scholar
• Vyas TK, Shahiwala A, Amiji MM. 2008. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm. 347:93–101.
   PubMed Web of Science ®Google Scholar
• Wållberg M, Bergquist J, Achour A, Breij E, Harris RA. 2007. Malondialdehyde modification of myelin oligodendrocyte glycoprotein leads to increased immunogenicity and encephalitogenicity. Eur J Immunol. 37:1986–1995.
   PubMed Web of Science ®Google Scholar
• Wang C, Wu C, Zhu J, Miller RH, Wang Y. 2011a. Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination. J Med Chem. 54:2331–2340.
   PubMed Web of Science ®Google Scholar
• Wang H, Leeuwenburgh SC, Li Y, Jansen JA. 2011b. The use of micro- and nanospheres as functional components for bone tissue regeneration. Tissue Eng B Rev. 18:24–39.
   PubMed Web of Science ®Google Scholar
• Wang Y, Su W, Li Q, Li C, Wang H, Li Y, Cao Y, Chang J, Zhang L. 2013. Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery. Int J Pharm. 441:748–756.
   PubMed Web of Science ®Google Scholar
• Warntjes J, Leinhard OD, West J, Lundberg P. 2008. Rapid magnetic resonance quantification on the brain: Optimization for clinical usage. Magn Resonance Med. 60:320–329.
   PubMed Web of Science ®Google Scholar
• Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med. 12:317–323.
   PubMed Web of Science ®Google Scholar
• Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA. 2010. Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab. 30:15–35.
   PubMed Web of Science ®Google Scholar
• Weissert R. 2013. The immune pathogenesis of multiple sclerosis. J Neuroimmune Pharmacol. 8:857–866.
   PubMed Web of Science ®Google Scholar
• Wickline SA, Lanza GM. 2003. Nanotechnology for molecular imaging and targeted therapy. Circulation. 107:1092–1095.
   PubMed Web of Science ®Google Scholar
• Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. 2012. Nanoparticles as drug delivery systems. Pharmacol Rep. 64:1020–1037.
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Gelperina S, Kreuter J. 2012. Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release. 161:264–273.
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J. 2011. Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier. J Control Release. 154:103–107.
   PubMed Web of Science ®Google Scholar
• Wong HL, Wu XY, Bendayan R. 2012. Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliv Rev. 64:686–700.
   PubMed Web of Science ®Google Scholar
• Xie F, Yao N, Qin Y, Zhang Q, Chen H, Yuan M, Tang J, Li X, Fan W, Zhang Q. 2012. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting. Int J Nanomed. 7:163–175.
   PubMed Web of Science ®Google Scholar
• Xie Z-X, Zhang H-L, Wu X-J, Zhu J, Ma D-H, Jin T. 2015. Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis. Mediators Inflamm. 2015:513295.
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang H, Wu Y. 2013. Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem Neurosci. 5:2–13.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, Gao Y, Lin L, Zhang Z, Xi Y, Li Y. 2009. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 30:226–232.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Y, Yang Y, Sun L, Han D, Li H, Wang C. 2010. Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomed Nanotechnol Biol Med. 6:427–441.
   PubMed Web of Science ®Google Scholar
• Yazdani Y, Keyhanvar N, Kalhor HR, Rezaei A. 2013. Functional analyses of recombinant mouse hepcidin-1 in cell culture and animal model. Biotechnol Lett. 35:1191–1197.
   PubMed Web of Science ®Google Scholar
• Yazdani Y, Sadeghi H, Alimohammadian M, Andalib A, Moazen F, Rezaei A. 2011. Expression of an innate immune element (mouse hepcidin-1) in baculovirus expression system and the comparison of its function with synthetic human hepcidin-25. Iran J Pharm Res. 10:559–568.
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Q, Zhou X, Zhang N. 2008. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm. 352:273–279.
   PubMed Web of Science ®Google Scholar
• Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. 2012. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 109:11270–11275.
   PubMed Web of Science ®Google Scholar
• Youssef T, Fadel M, Fahmy R, Kassab K. 2012. Evaluation of hypericin-loaded solid lipid nanoparticles: Physicochemical properties, photostability and phototoxicity. Pharm Dev Technol. 17:177–186.
   PubMed Web of Science ®Google Scholar
• Yuan B, Zhao L, Fu F, Liu Y, Lin C, Wu X, Shen H, Yang Z. 2014. A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis. Mol Immunol. 57:93–99.
   PubMed Web of Science ®Google Scholar
• Yuan H, Wang L-L, Du Y-Z, You J, Hu F-Q, Zeng S. 2007. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf B Biointerfaces. 60:174–179.
   PubMed Web of Science ®Google Scholar
• Zhang P, Hu L, Yin Q, Feng L, Li Y. 2012. Transferrin-modified c [RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy. Mol Pharm. 9:1590–1598.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Petibone D, Xu Y, Mahmood M, Karmakar A, Casciano D, Ali S, Biris AS. 2014. Toxicity and efficacy of carbon nanotubes and graphene: The utility of carbon-based nanoparticles in nanomedicine. Drug Metab Rev. 46:232–246.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhao H, Chen Z, Lan M. 2014. Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent. J Nanosci Nanotechnol. 14:210–220.
   PubMed Web of Science ®Google Scholar
• Zhiryakova MV, Izumrudov VA. 2014. Interaction of astramol poly (propyleneimine) dendrimers with DNA and poly (methacrylate) anion in water and water–salt solutions. J Phys Chem B. 118:8819–8826.
   PubMed Web of Science ®Google Scholar
• Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng M-Q, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE. 2013. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci USA. 110:11751–11756.
   PubMed Web of Science ®Google Scholar
• Zhu S, Xu G. 2010. Single-walled carbon nanohorns and their applications. Nanoscale. 2:2538–2549.
   PubMed Web of Science ®Google Scholar